MedTrace Logo

Evaluate the Efficacy and Safety of DWP05195 in Subjects With Post-Herpetic Neuralgia

NCT01557010 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2014-02-21

No results posted yet for this study

Summary

The purpose of this study is to evaluate efficacy, safety of administered DWP05195 in Postherpetic Neuralgia.

Conditions

  • Postherpetic Neuralgia

Interventions

DRUG

DWP05195

Tablets, oral administration, 100mg

DRUG

DWP05195

Tablets, oral administration, 200mg

DRUG

DWP05195

Tablets, oral administration, 300mg

DRUG

Control

Tablets, oral administration, Placebo

Sponsors & Collaborators

  • Daewoong Pharmaceutical Co. LTD.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2013-11-30
Completion
2013-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01557010 on ClinicalTrials.gov